Friday, October 7, 2022
HomeBusinessNextEra, Danaher, Rhythm Pharmaceuticals and more

NextEra, Danaher, Rhythm Pharmaceuticals and more

Date:

Related stories

Samsung Electronics Q3 profit likely fell 32% as demand slumped in downturn By Reuters

© Reuters. SEOUL (Reuters) - Samsung Electronics (OTC:)...

Inside a $150 million Hamptons summer home for sale

An oceanfront estate in Southampton, listed at $150...

Twitter arbitrage bet could pay off big for Pentwater Capital

Jakub Porzycki | Nurphoto | Getty ImagesAmong the...

4 Things You Must Know Before Raising Seed Funding for Startup

The greatest innovations on earth originated from ideas. These...


Wind turbines at the San Gorgonio Pass wind farm, owned by NextEra Energy Inc., in Whitewater, California, on Wednesday, Feb. 17, 2021.

Bing Guan | Bloomberg | Getty Images

Check out the companies making headlines after hours.

NextEra Energy — Shares fell 3% in extended trading after the company announced its intent to sell $2 billion in equity units. Each equity unit will be issued in the amount of $50 and will consist of a contract to purchase NextEra Energy common stock in the future, as well as a 5% undivided beneficial ownership interest in a NextEra Energy Capital Holdings debenture due Sept. 1, 2027, issued in the principal amount of $1,000.

Danaher — The medical company saw shares rise 4% after announcing plans to spin off its environmental and applied solutions business to create an independent, publicly traded company. It also raised its third-quarter revenue guidance, according to FactSet.

Rhythm Pharmaceuticals — Shares of Rhythm Pharmaceuticals fell about 11% after the company announced a $100 million stock offering.

Arconic Corp — The manufacturing company’s shares slid about 8% after Arconic provided a lower-than-previously-expected revenue forecast for the full year, citing the impact of operational issues and the combination of demand declines and higher unhedged energy costs in Europe.



Source link

Latest stories